Business
Starpharma (ASX:SPL) share price dips on quarterly update // The Motley Fool Australia
The Starpharma Holdings Limited (ASX: SPL) share price has dipped slightly today after the company released its quarterly cashflow and activities report for the quarter ended 31 December 2020.
Starpharma is a global biopharmaceutical company that develops pharmaceutical and medical products based on proprietary polymers called dendrimers. Dendrimers are man-made nanoscale compounds that can be used both to enhance existing health products and as entirely new products.
The company is presently developing Viraleze, an antiviral nasal spray for COVID-19 that is complementary to vaccines and other preventative measures.
Here are some highlights from the company’s quarterly update.
Starpharma developments during the December…
-
Noosa News9 hours agoArnie the dog found dead in stolen ute after week of searching
-
Noosa News9 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car
-
Noosa News16 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News15 hours agoTeenage girl dies in hit-and-run, police hunt for ute